Clinical study for monitoring of therapy effect on breast cancer using 18F-fluoromisonidazole PET/CT
Not Applicable
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000006802
- Lead Sponsor
- Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 43
Inclusion Criteria
Not provided
Exclusion Criteria
1) Pregnant female or female having possibility of pregnancy 2) Patients ineligible for participating in this study because of other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relation between the shrinkage and the FMISO uptake in the breast cancer after 2-4 cycles of chemotherapy and after completion of therapy.
- Secondary Outcome Measures
Name Time Method Relation between the prognosis and the FMISO uptake in the breast cancer after 2-4 cycles of chemotherapy and after completion of therapy.